Cancer Patients Aid Association hails SC's verdict

CNN-IBN | Apr 01, 2013 at 02:14pm

In a landmark verdict, the Supreme Court of India dismissed a plea by the Swiss pharmaceutical giant Novartis on Monday for a patent on its cancer drug Glivec, paving way for more affordable life saving cancer drugs. 'Generic companies will have a levy that will allow them to survive in India for a considerable period of time,' said Anand Grover, lawyer, Cancer Patients Aid Association.